BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 18466349)

  • 1. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.
    Bahr MJ; Boeker KH; Manns MP; Tietge UJ
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):60-5. PubMed ID: 18466349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
    Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
    Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.
    Ulgen F; Herder C; Kühn MC; Willenberg HS; Schott M; Scherbaum WA; Schinner S
    Arch Physiol Biochem; 2010 May; 116(2):57-62. PubMed ID: 20222849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
    Tietge UJ; Böker KH; Manns MP; Bahr MJ
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance.
    Bahr MJ; Ockenga J; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E199-206. PubMed ID: 16478779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance].
    Lu HY; Li XF; Mu PW; Jiang W; Zeng LY
    Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3395-8. PubMed ID: 21223811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum retinol-binding protein 4 is associated with insulin resistance in older women.
    Suh JB; Kim SM; Cho GJ; Choi KM; Han JH; Taek Geun H
    Metabolism; 2010 Jan; 59(1):118-22. PubMed ID: 19766271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
    Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents.
    Lee DC; Lee JW; Im JA
    Metabolism; 2007 Mar; 56(3):327-31. PubMed ID: 17292720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.
    Cho YM; Youn BS; Lee H; Lee N; Min SS; Kwak SH; Lee HK; Park KS
    Diabetes Care; 2006 Nov; 29(11):2457-61. PubMed ID: 17065684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects.
    Broch M; Vendrell J; Ricart W; Richart C; Fernández-Real JM
    Diabetes Care; 2007 Jul; 30(7):1802-6. PubMed ID: 17416795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
    Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
    Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma resistin concentrations in patients with liver cirrhosis.
    Kakizaki S; Sohara N; Yamazaki Y; Horiguchi N; Kanda D; Kabeya K; Katakai K; Sato K; Takagi H; Mori M
    J Gastroenterol Hepatol; 2008 Jan; 23(1):73-7. PubMed ID: 18171344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinol-binding protein 4 in young men with low versus normal birth weight: physiological response to short-term overfeeding.
    Ribel-Madsen R; Brøns C; Friedrichsen M; Poulsen P; Vaag A
    Obesity (Silver Spring); 2011 Jun; 19(6):1304-6. PubMed ID: 21164503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.
    Petrides AS; Stanley T; Matthews DE; Vogt C; Bush AJ; Lambeth H
    Hepatology; 1998 Jul; 28(1):141-9. PubMed ID: 9657106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
    Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
    Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinol binding protein 4 and insulin resistance in apparently healthy elderly subjects.
    Lee JW; Im JA; Park KD; Lee HR; Shim JY; Lee DC
    Clin Chim Acta; 2009 Feb; 400(1-2):30-2. PubMed ID: 18977339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
    Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
    Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.